Technical Data
P4257-84A
PAFAH (Platelet-activating Factor Acetylhydrolase, PAF Acetylhydrolase, 1-alkyl-2-acetylglycerophosphocholine Esterase, 2-acetyl-1-alkylglycerophosphocholine Esterase, Group-VIIA Phospholipase A2, gVIIA-PLA2, LDL-associated Phospholipase A2, LDL-PLA(2), P
Description:
LP-PLA2 is an enzyme which circulates in the blood, and attaches to LDL cholesterol particles in the bloodstream. These particles can adhere to the arterial walls, where oxidation takes place which promotes the build-up of plaque in the arteries. Lp-PLA2 is considered currently considered a risk marker for cardiovascular disease and is measured through a simple blood test using ELISA.

Applications:
Suitable for use in ELISA, Western Blot, Dot Blot, Immunohistochemistry, Immunoassays, development of rapid tests and other antibody recognition assays. Other applications not tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGPurified
SizeStorageShippingSourceHost
1ml-20CBlue IceHumanSheep
Concentration:
As reported
Immunogen:
Recombinant human LP-PLA2 aa22-441 corresponding to mature LP-PLA2.
Purity:
Purified by ammonium sulfate precipitation.
Form
Supplied as a liquid in 20mM phosphate, 150mM sodium chloride, pH 7.2, 0.09% sodium azide.
Specificity:
Recognizes human LP-PLA2.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.